Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Prediabetic State 1Neoplasms 1Diabetes Mellitus, Type 2 1Diabetes Mellitus, Type 1 1Diabetes Mellitus 1Colorectal Neoplasms 1Bone Metastases 1

Interventions

relacorilant 5Resistance Training 3Pioglitazone 2Nutritional Status 2Metformin 2saxagliptin 1pembrolizumab 1mazdutide 1dapagliflozin 1Sitagliptin Phosphate 1Resistant Starch 1Plant Proteins 1Nutrition Assessment 1Methods 1Insulin Lispro 1Insulin Glargine 1Exercise Movement Techniques 1Exercise 1Ethanol 1Endodontics 1Educational Status 1Early Intervention, Educational 1Diet 1Continuous Glucose Monitoring 1Circuit-Based Exercise 1Cholecalciferol 1Blood Specimen Collection 1Ascorbic Acid 1ASP3662 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Diabetes Mellitus, Type 2 × Continuous Glucose Monitoring × Clear all
NCT04942756 2021-07-22

GLYPALCARE STUDY - Multicenter, Randomized Study for Evaluating Continuous Glucose Monitoring (CGM) by Using FreeStyle Libre 2 (FSL2) for Preventing Hyperglycemia/Hypoglycemia Crisis in Advanced Oncological Patients.

Antea Foundation

Phase NA Unknown
118 enrolled

Diabetes Mellitus, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡